LYRBX
Price
$27.38
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VMVAX
Price
$88.78
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

LYRBX vs VMVAX

Header iconLYRBX vs VMVAX Comparison
Open Charts LYRBX vs VMVAXBanner chart's image
Lyrical US Value Equity Investor
Price$27.38
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$88.78
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
LYRBX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LYRBX vs. VMVAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYRBX is a Sell and VMVAX is a Buy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.9B vs. LYRBX (1.14B). VMVAX pays higher dividends than LYRBX: VMVAX (2.14) vs LYRBX (0.20). LYRBX was incepted earlier than VMVAX: LYRBX (11 years) vs VMVAX (13 years). LYRBX (23.00) and VMVAX (22.00) have comparable annual turnover. LYRBX has a lower initial minimum investment than VMVAX: LYRBX (2500) vs VMVAX (3000). LYRBX annual gain was more profitable for investors over the last year : 33.47 vs. VMVAX (28.30). LYRBX return over 5 years is better than : 70.88 vs. VMVAX (48.86).
LYRBXVMVAXLYRBX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years13 years-
Gain YTD20.35218.476110%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.14B30.9B4%
Annual Yield % from dividends0.202.149%
Returns for 1 year33.4728.30118%
Returns for 3 years19.8014.98132%
Returns for 5 years70.8848.86145%
Returns for 10 years74.18100.7274%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
U19.13-0.09
-0.47%
Unity Software
MP19.12-0.73
-3.68%
MP Materials Corp
MLAB107.79-4.62
-4.11%
Mesa Laboratories
TTNP4.15-0.26
-6.00%
Titan Pharmaceuticals
LPTX2.99-0.25
-7.85%
Leap Therapeutics